Oral streptococci and nitrite-mediated interference of Pseudomonas aeruginosa

Infection and Immunity

Volumn 83, Issue 1, 2015, Pages 101-107

  Scoffield, Jessica A ^a   Wu, Hui ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; HYDROGEN PEROXIDE; KANAMYCIN; LACTIC ACID; NITRATE; NITRITE; PEROXYNITRITE; CARRIER PROTEIN; REACTIVE NITROGEN SPECIES;

ARTICLE; BACTERIAL GROWTH; BACTERIAL MEMBRANE; BACTERIAL STRAIN; CRYPTOSPORIDIUM PARVUM; CYSTIC FIBROSIS; DENTAL CARIES; DROSOPHILA MELANOGASTER; LIQUID CULTURE; LUNG FUNCTION; LUNG INFECTION; MOUTH CAVITY; MOUTH FLORA; NONHUMAN; PERIODONTITIS; PRIMARY INFECTION; PSEUDOMONAS AERUGINOSA; STREPTOCOCCUS; STREPTOCOCCUS GORDONII; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PARASANGUINIS; STREPTOCOCCUS SANGUINIS; TRANSPOSON; WILD TYPE; ANIMAL; ANTIBIOSIS; DRUG EFFECTS; GENE DELETION; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SURVIVAL ANALYSIS;

ANIMALS; ANTIBIOSIS; DROSOPHILA MELANOGASTER; GENE DELETION; HYDROGEN PEROXIDE; MEMBRANE TRANSPORT PROTEINS; MUTAGENESIS, INSERTIONAL; NITRITES; PSEUDOMONAS AERUGINOSA; REACTIVE NITROGEN SPECIES; STREPTOCOCCUS; SURVIVAL ANALYSIS;

EID: 84919491814     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02396-14     Document Type: Article

References (40)

1. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner ACR, Yu W-H, Lakshmanan A, Wade WG. 2010. The human oral microbiome. J Bacteriol 192:5002-5017. http://dx.doi.org/10.1128/JB.00542-10.
2. Kreth J, Merritt J, Qi F. 2009. Bacterial and host interactions of oral streptococci. DNA Cell Biol 28:397-403. http://dx.doi.org/10.1089/dna.2009.0868.
3. Nobbs AH, Lamont RJ, Jenkinson HF. 2009. Streptococcus adherence and colonization. Microbiol Mol Biol Rev 73:407-450. http://dx.doi.org/10.1128/MMBR.00014-09.
4. Takahashi N. 2005. Microbial ecosystem in the oral cavity: metabolic diversity in an ecological niche and its relationship with oral diseases. Int Congr Ser 1284:103-112. http://dx.doi.org/10.1016/j.ics.2005.06.071.
5. Seymour GJ, Ford PJ, Cullinan MP, Leishman S, Yamazaki K. 2007. Relationship between periodontal infections and systemic disease. Clin Microbiol Infect 4:3-10.
6. Paik S, Senty L, Das S, Noe JC, Munro L, Kitten T, Munro CL. 2005. Identification of virulence determinants for endocarditis in Streptococcus sanguinis by signature-tagged mutagenesis. Infect Immun 73:6064-6074. http://dx.doi.org/10.1128/IAI.73.9.6064-6074.2005.
7. Gomes-Filho IS, Passos JS, Seixas da Cruz S. 2010. Respiratory disease and the role of oral bacteria. J Oral Microbiol 2:1-6. http://dx.doi.org/10.3402/jom.v2i0.5811.
8. Filkins LM, Hampton T, Gifford A, Gross M, Hogan D, Sogin M, Morrison H, Pastor B, O'Toole GA. 2012. The prevalence of streptococci and increased polymicrobial diversity associated with cystic fibrosis patient stability. J Bacteriol 194:4709-4717. http://dx.doi.org/10.1128/JB.00566-12.
9. Gilligan P. 1991. Microbiology of airway disease in patients with cystic fibrosis. Clin Microbiol Rev 4:35-51.
10. Smith E, Buckley E, Wu D, Saenphimmachak Z, Hoffman C, D'Argenio L, Miller D, Ramsey S, Speert B. 2006. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103:8487-8492. http://dx.doi.org/10.1073/pnas.0602138103.
11. Bragonzi A, Paroni M, Nonis A, Cramer N, Montanari S, Rejman J, Di Serio C, Döring G, Tümmler B. 2009. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence. Am J Respir Crit Care Med 180:138-145. http://dx.doi.org/10.1164/rccm.200812-1943OC.
12. Lee DG, Urbach JM, Wu G, Liberati NT, Feinbaum RL, Miyata S, Diggins LT, He J, Saucier M, Déziel E, Friedman L, Li L, Grills G, Montgomery K, Kucherlapati R, Rahme LG, Ausubel FM. 2006. Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol 7:R90. http://dx.doi.org/10.1186/gb-2006-7-10-r90.
13. Hagins JM, Scoffield JA, Suh S-J, Silo-Suh L. 2010. Influence of RpoN on isocitrate lyase activity in Pseudomonas aeruginosa. Microbiology 156: 1201-1210. http://dx.doi.org/10.1099/mic.0.033381-0.
14. Hagins J, Scoffield J, Suh SJ, Silo-Suh L. 2011. Malate synthase expression is deregulated in the cystic fibrosis isolate FRD1. Can J Microbiol 195:186-195.
15. Hogardt M, Heesemann J. 2010. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung. Int J Med Microbiol 300:557-562. http://dx.doi.org/10.1016/j.ijmm.2010.08.008.
16. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, Perez JL, Oliver A. 2008. Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 190:7910-7917. http://dx.doi.org/10.1128/JB.01147-08.
17. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. 1999. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrob Agents Chemother 43:1379-1382.
18. Kreth J, Zhang Y, Herzberg MC. 2008. Streptococcal antagonism in oral biofilms: Streptococcus sanguinis and Streptococcus gordonii interference with Streptococcus mutans. J Bacteriol 190:4632-4640. http://dx.doi.org/10.1128/JB.00276-08.
19. Suarez A, Guttler A, Stratz M, Staendner LH, Timmis KN, Guzman CA. 1997. Green fluorescent protein-based reporter systems for genetic analysis of bacteria including monocopy applications. Gene 196:69-74. http://dx.doi.org/10.1016/S0378-1119(97)00197-2.
20. Schweizer HD. 1993. Small broad-host-range gentamicin resistance gene cassettes for site-specific insertion and deletion mutagenesis. Biotechniques 15:831-833.
21. Suh SJ, Silo-Suh LA, Ohman DE. 2004. Development of tools for the genetic manipulation of Pseudomonas aeruginosa. J Microbiol Methods 58:203-212. http://dx.doi.org/10.1016/j.mimet.2004.03.018.
22. Chen L, Ge X, Wang X, Patel JR, Xu P. 2012. SpxA1 involved in hydrogen peroxide production, stress tolerance and endocarditis viru-lence in Streptococcus sanguinis. PLoS One 7:e40034. http://dx.doi.org/10.1371/journal.pone.0040034.
23. Apidianakis Y, Rahme LG. 2009. Drosophila melanogaster as a model host for studying Pseudomonas aeruginosa infection. Nat Protoc 4:1285-1294. http://dx.doi.org/10.1038/nprot.2009.124.
24. Grasemann H, Ioannidis I, Tomkiewicz RP, de Groot H, Rubin BK, Ratjen F. 1998. Nitric oxide metabolites in cystic fibrosis lung disease. Arch Dis Child 78:49-53. http://dx.doi.org/10.1136/adc.78.1.49.
25. Linnane SJ, Keatings VM, Costello CM, Moynihan JB, O'Connor CM, Fitzgerald MX, McLoughlin P. 1998. Total sputum nitrate plus nitrite is raised during acute pulmonary infection in cystic fibrosis. Am J Respir Crit Care Med 158:207-212.
26. Watanabe K, Senba M, Ichinose A, Yamamoto T. 2009. Bactericidal activity in filtrated supernatant of Streptococcus sanguinis against multidrug-resistant Pseudomonas aeruginosa. Tohoku J Exp Med 219:79-84. http://dx.doi.org/10.1620/tjem.219.79.
27. Major TA, Panmanee W, Mortensen JE, Gray LD, Hoglen N, Hassett DJ. 2010. Sodium nitrite-mediated killing of the major cystic fibrosis pathogens Pseudomonas aeruginosa, Staphylococcus aureus, and Burkholderia cepacia under anaerobic planktonic and biofilm conditions. Antimicrob Agents Chemother 54:4671-4677. http://dx.doi.org/10.1128/AAC.00379-10.
28. Yoon SS, Coakley R, Lau GW, Lymar SV, Gaston B, Karabulut AC, Hennigan RF, Hwang S, Buettner G, Schurr MJ, Mortensen JE, Burns JL, Speert D, Boucher RC, Hassett DJ. 2006. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J Clin Invest 116:436-446. http://dx.doi.org/10.1172/JCI24684.
29. Alakomi HL, Skyttä E, Saarela M, Mattila-Sandholm T, Latva-Kala K, Helander IM. 2000. Lactic acid permeabilizes gram-negative bacteria by disrupting the outer membrane. Appl Environ Microbiol 66:2001-2005. http://dx.doi.org/10.1128/AEM.66.5.2001-2005.2000.
30. Dashper SG, Reynolds EC. 1984. Lactic acid excretion by Streptococcus mutans. Microbiology 142:33-39.
31. Pacher L, Beckman JS, Liaudet L. 2007. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315-424. http://dx.doi.org/10.1152/physrev.00029.2006.
32. Szabó C, Ischiropoulos H, Radi R. 2007. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 6:662-680. http://dx.doi.org/10.1038/nrd2222.
33. Dela Vega A, Delcour AH. 1996. Polyamines decrease Escherichia coli outer membrane permeability. J Bacteriol 178:3715-3721.
34. Bower JM, Mulvey MA. 2006. Polyamine-mediated resistance of uropathogenic Escherichia coli to nitrosative stress. J Bacteriol 188:928-933. http://dx.doi.org/10.1128/JB.188.3.928-933.2006.
35. Darrah PA, Hondalus MK, Chen Q, Mosser DM, Ischiropoulos H. 2000. Cooperation between reactive oxygen and nitrogen intermediates in killing of Rhodococcus equi by activated macrophages. Infect Immun 68: 3587-3593. http://dx.doi.org/10.1128/IAI.68.6.3587-3593.2000.
36. Genest PC, Setlow B, Melly E, Setlow P. 2002. Killing of spores of Bacillus subtilis by peroxynitrite appears to be caused by membrane damage. Microbiology 148:307-314.
37. Gookin JL, Allen J, Chiang S, Duckett L, Armstrong MU, Carolina N. 2005. Local peroxynitrite formation contributes to early control of Cryptosporidium parvum infection. Infect Immun 73:3929-3936. http://dx.doi.org/10.1128/IAI.73.7.3929-3936.2005.
38. McLean S, Bowman LAH, Sanguinetti G, Read RC, Poole RK. 2010. Peroxynitrite toxicity in Escherichia coli K12 elicits expression of oxidative stress responses and protein nitration and nitrosylation. J Biol Chem 285: 20724-20731. http://dx.doi.org/10.1074/jbc.M109.085506.
39. Tecder-Unal M, Can F, Demirbilek M, Karabay G, Tufan H, Arslan H. 2008. The bactericidal and morphological effects of peroxynitrite on Helicobacter pylori. Helicobacter 13:42-48. http://dx.doi.org/10.1111/j.1523-5378.2008.00583.x.
40. He X, Hu W, He J, Guo L, Lux R, Shi W. 2011. Community-based interference against integration of Pseudomonas aeruginosa into human salivary microbial biofilm. Mol Oral Microbiol 26:337-352. http://dx.doi.org/10.1111/j.2041-1014.2011.00622.x.